

Author: Schmid Molly B
Publisher: Informa Healthcare
ISSN: 1472-8222
Source: Expert Opinion on Therapeutic Targets, Vol.5, Iss.4, 2001-08, pp. : 465-475
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




Genomics and new targets for multiple sclerosis
By Baranzini Sergio E Oksenberg Jorge R
Pharmacogenomics, Vol. 6, Iss. 2, 2005-03 ,pp. :


New Targets for Antithrombotic Drugs
American Journal of Cardiovascular Drugs, Vol. 2, Iss. 4, 2002-01 ,pp. :

